Summary
- Sharon Greeves, a breast cancer survivor, welcomed the approval of the new breast cancer treatment drug abemaciclib by the HSE.
- Abemaciclib, taken in combination with hormone therapies, reduces the risk of cancer recurrence by 32%.
- The drug will be available on prescription in Ireland for individuals with high-risk oestrogen-driven breast cancer.
- Greeves expressed gratitude for the new treatment option, providing hope for those battling the disease.
